Illini, O.
5  Ergebnisse:
?
1

EP02.01-008 Clinicopathological Features of Rare but Target..:

Zacharias, M. ; Konjic, S. ; Absenger, G....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S201-S202 , 2022
 
?
2

EP08.02-122 Real-world Experience with Capmatinib in MET Ex..:

Illini, O. ; Fabikan, H. ; Swalduz, A....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S460 , 2022
 
?
3

Selpercatinib in RET fusion-positive non-small-cell lung ca..:

Illini O ; Hochmair M. J ; Fabikan H...
info:eu-repo/semantics/altIdentifier/pmid/34178121.  , 2021
 
?
4

Selpercatinib in RET fusion-positive non-small-cell lung ca..:

Illini, Oliver ; Hochmair, Maximilian Johannes ; Fabikan, Hannah...
Illini , O , Hochmair , M J , Fabikan , H , Weinlinger , C , Tufman , A , Swalduz , A , Lamberg , K , Hashemi , S M S , Huemer , F , Vikström , A , Wermke , M , Absenger , G , Addeo , A , Banerji , S , Calles , A , Clarke , S , di Maio , M , Durand , A , Duruisseaux , M , Itchins , M , Kääränien , O-S , Krenn , F , Laack , E , de Langen , A J , Mohorcic , K , Pall , G , Passaro , A , Prager , G , Rittmeyer , A , Rothenstein , J , Schumacher , M , Wöll , E & Valipour , A 2021 , ' Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program ' , Therapeutic Advances in Medical Oncology , vol. 13 . https://doi.org/10.1177/17588359211019675.  , 2021
 
1-5
Mehr Literatur finden